FMP
Charles River Laboratories International, Inc.
CRL
NYSE
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
171.04 USD
4.11 (2.4%)
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2.92B
3.54B
3.98B
4.13B
4.05B
4.41B
4.8B
5.22B
5.68B
6.18B
-
21.08
12.31
3.86
-1.92
8.83
8.83
8.83
8.83
759.15M
854.29M
1.04B
1.03B
581.14M
1.02B
1.11B
1.21B
1.31B
1.43B
25.96
24.13
26.05
24.99
14.35
23.1
23.1
23.1
23.1
524.22M
588.75M
731.99M
717.99M
219.4M
667.97M
726.95M
791.14M
861M
937.03M
17.93
16.63
18.41
17.39
5.42
15.15
15.15
15.15
15.15
234.92M
265.54M
303.87M
314.12M
361.74M
350.11M
381.03M
414.68M
451.29M
491.14M
8.03
7.5
7.64
7.61
8.93
7.94
7.94
7.94
7.94
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
228.42M
241.21M
233.91M
276.77M
194.61M
282.23M
307.15M
334.28M
363.8M
395.92M
7.81
6.81
5.88
6.7
4.81
6.4
6.4
6.4
6.4
617.74M
642.88M
752.39M
780.38M
720.91M
836.64M
910.52M
990.92M
1.08B
1.17B
21.13
18.16
18.92
18.9
17.8
18.98
18.98
18.98
18.98
185.69M
199.15M
255.81M
380.26M
278.54M
304.09M
330.94M
360.17M
391.97M
426.59M
6.35
5.63
6.43
9.21
6.88
6.9
6.9
6.9
6.9
122.47M
198.13M
205.91M
168.94M
140.34M
198.52M
216.05M
235.13M
255.9M
278.49M
4.19
5.6
5.18
4.09
3.47
4.5
4.5
4.5
4.5
-166.56M
-228.77M
-324.73M
-318.53M
-232.97M
-297.88M
-324.19M
-352.81M
-383.97M
-417.88M
-5.7
-6.46
-8.17
-7.71
-5.75
-6.76
-6.76
-6.76
-6.76
171.04
51.63M
4.64
1.11
2.72B
8.83B
11.55B
23.58
76.42
9.11
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2.92B
3.54B
3.98B
4.13B
4.05B
4.41B
4.8B
5.22B
5.68B
6.18B
759.15M
854.29M
1.04B
1.03B
581.14M
1.02B
1.11B
1.21B
1.31B
1.43B
524.22M
588.75M
731.99M
717.99M
219.4M
667.97M
726.95M
791.14M
861M
937.03M
76.16
76.16
76.16
76.16
76.16
76.16
76.16
76.16
76.16
76.16
427.13M
478.86M
571.3M
586.25M
52.32M
462.71M
503.57M
548.04M
596.43M
649.1M
234.92M
265.54M
303.87M
314.12M
361.74M
350.11M
381.03M
414.68M
451.29M
491.14M
617.74M
642.88M
752.39M
780.38M
720.91M
836.64M
910.52M
990.92M
1.08B
1.17B
185.69M
199.15M
255.81M
380.26M
278.54M
304.09M
330.94M
360.17M
391.97M
426.59M
122.47M
198.13M
205.91M
168.94M
140.34M
198.52M
216.05M
235.13M
255.9M
278.49M
-166.56M
-228.77M
-324.73M
-318.53M
-232.97M
-297.88M
-324.19M
-352.81M
-383.97M
-417.88M
-185.47M
552.69M
392.05M
392.43M
313.67M
431.85M
477.21M
519.35M
565.21M
615.12M
9.11
9.11
9.11
9.11
9.11
395.8M
400.85M
399.82M
398.8M
397.77M
1.99B
9.11
633.57M
10.38B
6.71B
8.7B
2.53B
6.17B
51.63M
119.6
119.6 -0.43%